Psychopharmacology and Substance Abuse

Division 28: The Division of Psychopharmacology and Substance Abuse promotes teaching, research, and dissemination of information regarding the effects of drugs on behavior.

The Division was formed in 1967 to provide a home within APA for psychologists interested in the behavioral effects of psychoactive or central nervous system medicine, drugs and chemicals. Our research often combines the methods of psychology and pharmacology to study the interaction of behavior, drugs, and other environmental factors in animals and humans. It is conducted in laboratory, clinical, and community settings.

The Division addresses issues related to animal research, neurobehavioral toxicology, psychopharmacology training programs, development of new treatments for drug addiction, and public policy related to medication regulation and substance abuse.

President

Anthony Liguori, PhD, Wake Forest School of Medicine, Winston-Salem, N.C.
View a list of past presidents

Secretary

William W. Stoops, PhD, University of Kentucky College of Medicine, Lexington, Ky.

Newsletter

Psychopharmacology and Substance Abuse News (published three times/year)
Editor: Kelly E. Dunn, PhD, Johns Hopkins Medical Institute, Baltimore, Md.

Read about Division 28 in the Monitor

Studying substance abuse treatment in the field

Division 28 members are helping bring together research and practice in substance abuse treatment through a national trials network.

• Collaborative Perspectives on Addiction Conference (Division 28/50 Joint Conference)
  May 3-4, 2013
  Atlanta, Ga.

• APA Annual Convention 

Ryan Vandrey, PhD, Membership Chair
Behavioral Pharmacology Research Unit
Johns Hopkins University School of Medicine
5510 Nathan Shock Dr.
Baltimore, MD 21224
Telephone: (410) 550-4036
Fax: (410) 550-0030